Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer

OBJECTIVE: Pt-Mal-LHRH is a newly synthesized chemotherapeutic agent that was designed to selectively target the luteinizing hormone-releasing hormone (LHRH) receptor expressed by triple negative breast cancer (TNBC). The aim of this study was to evaluate the therapeutic dosing, tumor reduction effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndinguri, Margaret, Middleton, Lisa, Unrine, Jason, Lui, Shu, Rollins, Joseph, Nienaber, Emma, Spease, Cassidy, Williams, Aggie, Cormier, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564129/
https://www.ncbi.nlm.nih.gov/pubmed/37816015
http://dx.doi.org/10.1371/journal.pone.0287151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564129/
https://www.ncbi.nlm.nih.gov/pubmed/37816015
http://dx.doi.org/10.1371/journal.pone.0287151

Ejemplares similares